![](https://medfyle.com/articles/02-fidelio-dkd-outcomes-in-high-risk-ckd-and-type-2-diabetes/download_file?filename=articles%2F572_libraryimage.png)
![](https://medfyle.com/files/organizations/desg.png)
FIDELIO-DKD: cardiorenal outcomes in people with high-risk CKD and type 2 diabetes
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the Virtual EASD Annual Meeting 2021 and presented by:
Prof. George Bakris
University of Chicago
Chicago, IL, USA
The content is produced by Infomedica. The presenting authors of the original session had no part in the creation of this conference highlights summary.
References
1. Bakris GL, Agarwal R, Anker SD, et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020;383(23):2219-2229.